182 related articles for article (PubMed ID: 36507848)
1. Is Diminazene an Angiotensin-Converting Enzyme 2 (ACE2) Activator? Experimental Evidence and Implications.
Esfahani SH; Jayaraman S; Karamyan VT
J Pharmacol Exp Ther; 2022 Nov; 383(2):149-156. PubMed ID: 36507848
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin-converting enzyme 2 (ACE2) activator diminazene aceturate ameliorates endotoxin-induced uveitis in mice.
Qiu Y; Shil PK; Zhu P; Yang H; Verma A; Lei B; Li Q
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3809-18. PubMed ID: 24854854
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin-converting enzyme 2 activator diminazene aceturate prevents lipopolysaccharide-induced inflammation by inhibiting MAPK and NF-κB pathways in human retinal pigment epithelium.
Tao L; Qiu Y; Fu X; Lin R; Lei C; Wang J; Lei B
J Neuroinflammation; 2016 Feb; 13():35. PubMed ID: 26862037
[TBL] [Abstract][Full Text] [Related]
4. Effect of spinal angiotensin-converting enzyme 2 activation on the formalin-induced nociceptive response in mice.
Nemoto W; Yamagata R; Nakagawasai O; Nakagawa K; Hung WY; Fujita M; Tadano T; Tan-No K
Eur J Pharmacol; 2020 Apr; 872():172950. PubMed ID: 31987711
[TBL] [Abstract][Full Text] [Related]
5. Antiglaucomatous effects of the activation of intrinsic Angiotensin-converting enzyme 2.
Foureaux G; Nogueira JC; Nogueira BS; Fulgêncio GO; Menezes GB; Fernandes SO; Cardoso VN; Fernandes RS; Oliveira GP; Franca JR; Faraco AA; Raizada MK; Ferreira AJ
Invest Ophthalmol Vis Sci; 2013 Jun; 54(6):4296-306. PubMed ID: 23702784
[TBL] [Abstract][Full Text] [Related]
6. Diminazene aceturate enhances angiotensin-converting enzyme 2 activity and attenuates ischemia-induced cardiac pathophysiology.
Qi Y; Zhang J; Cole-Jeffrey CT; Shenoy V; Espejo A; Hanna M; Song C; Pepine CJ; Katovich MJ; Raizada MK
Hypertension; 2013 Oct; 62(4):746-52. PubMed ID: 23959549
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin-Converting Enzyme 2 Activation Mitigates Behavioral Deficits and Neuroinflammatory Burden in 6-OHDA Induced Experimental Models of Parkinson's Disease.
Gupta S; Tiwari V; Tiwari P; Parul ; Mishra A; Hanif K; Shukla S
ACS Chem Neurosci; 2022 May; 13(10):1491-1504. PubMed ID: 35533351
[TBL] [Abstract][Full Text] [Related]
8. ACE2 activator diminazene aceturate ameliorates Alzheimer's disease-like neuropathology and rescues cognitive impairment in SAMP8 mice.
Duan R; Xue X; Zhang QQ; Wang SY; Gong PY; E Y; Jiang T; Zhang YD
Aging (Albany NY); 2020 Jul; 12(14):14819-14829. PubMed ID: 32701063
[TBL] [Abstract][Full Text] [Related]
9. The beneficial effects of angiotensin-converting enzyme II (ACE2) activator in pulmonary hypertension secondary to left ventricular dysfunction.
Chen IC; Lin JY; Liu YC; Chai CY; Yeh JL; Hsu JH; Wu BN; Dai ZK
Int J Med Sci; 2020; 17(16):2594-2602. PubMed ID: 33029102
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of the ACE2/Ang-(1-7)/Mas axis in hypertensive pregnant rats attenuates cardiovascular dysfunction in adult male offspring.
Bessa ASM; Jesus ÉF; Nunes ADC; Pontes CNR; Lacerda IS; Costa JM; Souza EJ; Lino-Júnior RS; Biancardi MF; Dos Santos FCA; Pedrino GR; Colugnati DB; Mazaro-Costa R; Mendes EP; Castro CH
Hypertens Res; 2019 Dec; 42(12):1883-1893. PubMed ID: 31506648
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme 2 activator, DIZE in the basolateral amygdala attenuates the tachycardic response to acute stress by modulating glutamatergic tone.
Silva CC; Correa AMB; Kushmerick C; Sharma NM; Patel KP; de Almeida JFQ; Moreira FA; Ferreira AJ; Fontes MAP
Neuropeptides; 2020 Oct; 83():102076. PubMed ID: 32800589
[TBL] [Abstract][Full Text] [Related]
12. [ACE2 agonist DIZE alleviates lung injury induced by limb ischemia-reperfusion in mice].
Li SM; Wang XY; Liu F; Yang XH
Sheng Li Xue Bao; 2018 Apr; 70(2):175-183. PubMed ID: 29691582
[TBL] [Abstract][Full Text] [Related]
13. The potential actions of angiotensin-converting enzyme II (ACE2) activator diminazene aceturate (DIZE) in various diseases.
Qaradakhi T; Gadanec LK; McSweeney KR; Tacey A; Apostolopoulos V; Levinger I; Rimarova K; Egom EE; Rodrigo L; Kruzliak P; Kubatka P; Zulli A
Clin Exp Pharmacol Physiol; 2020 May; 47(5):751-758. PubMed ID: 31901211
[TBL] [Abstract][Full Text] [Related]
14. Diminazene protects corpus cavernosum against hypercholesterolemia-induced injury.
Fraga-Silva RA; Costa-Fraga FP; Montecucco F; Sturny M; Faye Y; Mach F; Pelli G; Shenoy V; da Silva RF; Raizada MK; Santos RA; Stergiopulos N
J Sex Med; 2015 Feb; 12(2):289-302. PubMed ID: 25411084
[TBL] [Abstract][Full Text] [Related]
15. The angiotensin converting enzyme 2/angiotensin-(1-7)/Mas Receptor axis as a key player in alveolar bone remodeling.
Queiroz-Junior CM; Santos ACPM; Galvão I; Souto GR; Mesquita RA; Sá MA; Ferreira AJ
Bone; 2019 Nov; 128():115041. PubMed ID: 31442676
[TBL] [Abstract][Full Text] [Related]
16. ACE2 Attenuates Epithelial-Mesenchymal Transition in MLE-12 Cells Induced by Silica.
Li S; Li Y; Xu H; Wei Z; Yang Y; Jin F; Zhang M; Wang C; Song W; Huo J; Zhao J; Yang X; Yang F
Drug Des Devel Ther; 2020; 14():1547-1559. PubMed ID: 32368013
[TBL] [Abstract][Full Text] [Related]
17. Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT
Goru SK; Kadakol A; Malek V; Pandey A; Sharma N; Gaikwad AB
Br J Pharmacol; 2017 Sep; 174(18):3118-3130. PubMed ID: 28688122
[TBL] [Abstract][Full Text] [Related]
18. Is the cardioprotective effect of the ACE2 activator diminazene aceturate more potent than the ACE inhibitor enalapril on acute myocardial infarction in rats?
Badae NM; El Naggar AS; El Sayed SM
Can J Physiol Pharmacol; 2019 Jul; 97(7):638-646. PubMed ID: 30840489
[TBL] [Abstract][Full Text] [Related]
19. Activation of Angiotensin-converting Enzyme 2 Protects Against Lipopolysaccharide-induced Glial Activation by Modulating Angiotensin-converting Enzyme 2/Angiotensin (1-7)/Mas Receptor Axis.
Tiwari P; Tiwari V; Gupta S; Shukla S; Hanif K
Mol Neurobiol; 2023 Jan; 60(1):203-227. PubMed ID: 36251234
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-κB and Nrf2 pathways.
Fang Y; Gao F; Liu Z
QJM; 2019 Dec; 112(12):914-924. PubMed ID: 31393582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
